These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676 [TBL] [Abstract][Full Text] [Related]
4. Correction: miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Apr; 124(9):1610. PubMed ID: 33473173 [No Abstract] [Full Text] [Related]
5. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502 [TBL] [Abstract][Full Text] [Related]
6. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling. Chen LY; Zhi Z; Wang L; Zhao YY; Deng M; Liu YH; Qin Y; Tian MM; Liu Y; Shen T; Sun LN; Li JM J Pathol; 2019 May; 248(1):103-115. PubMed ID: 30666650 [TBL] [Abstract][Full Text] [Related]
7. MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling. Hu Y; Liu J; Jiang B; Chen J; Fu Z; Bai F; Jiang J; Tang Z Dig Dis Sci; 2014 Sep; 59(9):2163-72. PubMed ID: 24711074 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines. Azizi R; Salemi Z; Fallahian F; Aghaei M J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567 [TBL] [Abstract][Full Text] [Related]
9. Altered Expression of DDR1 in Clear Cell Renal Cell Carcinoma Correlates With miR-199a/b-5p and Patients' Outcome. Krazinski BE; Kiewisz J; Sliwinska-Jewsiewicka A; Kowalczyk AE; Grzegrzolka J; Godlewski J; Kwiatkowski P; Dziegiel P; Kmiec Z Cancer Genomics Proteomics; 2019; 16(3):179-193. PubMed ID: 31018949 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321 [TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells. Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590 [TBL] [Abstract][Full Text] [Related]
12. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma. Ren L; Xu Y; Qin G; Liu C; Yan Y; Zhang H IUBMB Life; 2019 Jan; 71(1):28-40. PubMed ID: 30325582 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway. Sun W; Zu S; Shao G; Wang W; Gong F J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171 [TBL] [Abstract][Full Text] [Related]
14. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2. Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808 [TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines. Azizi R; Fallahian F; Aghaei M; Salemi Z Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493 [TBL] [Abstract][Full Text] [Related]
16. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines. Chappell WH; Candido S; Abrams SL; Akula SM; Steelman LS; Martelli AM; Ratti S; Cocco L; Cervello M; Montalto G; Nicoletti F; Libra M; McCubrey JA Aging (Albany NY); 2020 Jun; 12(11):10194-10210. PubMed ID: 32492656 [TBL] [Abstract][Full Text] [Related]
17. MiRNA-199a-5p Protects Against Cerebral Ischemic Injury by Down-Regulating DDR1 in Rats. Li M; Luan L; Liu Q; Liu Y; Lan X; Li Z; Liu W World Neurosurg; 2019 Nov; 131():e486-e494. PubMed ID: 31382062 [TBL] [Abstract][Full Text] [Related]
18. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression. Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276 [TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition. Koh M; Woo Y; Valiathan RR; Jung HY; Park SY; Kim YN; Kim HR; Fridman R; Moon A Int J Cancer; 2015 Mar; 136(6):E508-20. PubMed ID: 25155634 [TBL] [Abstract][Full Text] [Related]
20. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis. Lu J; Chen Y; Wen L; Zhou Q; Yan S J Gene Med; 2022 Jan; 24(1):e3389. PubMed ID: 34559933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]